49 related articles for article (PubMed ID: 31390053)
1. Anaplastic lymphoma kinase 5A4 immunohistochemistry as a diagnostic assay in lung cancer: A Canadian reference testing center's results in population-based reflex testing.
Fiset PO; Labbé C; Young K; Craddock KJ; Smith AC; Tanguay J; Pintilie M; Wang R; Torlakovic E; Cheung C; da Cunha Santos G; Ko HM; Boerner SL; Hwang DM; Leighl NB; Tsao MS
Cancer; 2019 Nov; 125(22):4043-4051. PubMed ID: 31390053
[TBL] [Abstract][Full Text] [Related]
2. Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry.
Conde E; Suárez-Gauthier A; Benito A; Garrido P; García-Campelo R; Biscuola M; Paz-Ares L; Hardisson D; de Castro J; Camacho MC; Rodriguez-Abreu D; Abdulkader I; Ramirez J; Reguart N; Salido M; Pijuán L; Arriola E; Sanz J; Folgueras V; Villanueva N; Gómez-Román J; Hidalgo M; López-Ríos F
PLoS One; 2014; 9(9):e107200. PubMed ID: 25248157
[TBL] [Abstract][Full Text] [Related]
3. Concordance of Immunohistochemistry and Fluorescence In Situ Hybridization in the Detection of Anaplastic Lymphoma Kinase (ALK) and Ros Proto-oncogene 1 (ROS1) Gene Rearrangements in Non-Small Cell Lung Carcinoma: A 4.5-Year Experience Highlighting Challenges and Pitfalls.
Nambirajan A; Sood R; Khatoon W; Malik PS; Mohan A; Jain D
Arch Pathol Lab Med; 2023 Dec; ():. PubMed ID: 38054562
[TBL] [Abstract][Full Text] [Related]
4. Discrepancies between ALK protein disruption and occurrence of
Grenda A; Jarosz B; Krawczyk P; Kucharczyk T; Wojas-Krawczyk K; Reszka K; Krukowska K; Nicoś M; Pankowski J; Bryl M; Ramlau R; Kuźnar-Kamińska B; Grodzki T; Szczęsna A; Siemiątkowska K; Szumiło J; Batura-Gabryel H; Palonka M; Milanowski J
J Thorac Dis; 2018 Aug; 10(8):4994-5009. PubMed ID: 30233874
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two immunohistochemical staining protocols for ALK demonstrates non-inferiority of a 5A4 clone-based protocol versus an ALK01 clone-based protocol for the diagnosis of ALK + anaplastic large cell lymphoma.
Fernandez-Pol S; Ferreira CR; Manohar V; Sanches JA; Lage LAPC; Pereira J; Zerbini MCN; Gratzinger D; Natkunam Y
J Hematop; 2023 Mar; 16(1):1-5. PubMed ID: 38175372
[TBL] [Abstract][Full Text] [Related]
6. Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.
Schink JC; Trosman JR; Weldon CB; Siziopikou KP; Tsongalis GJ; Rademaker AW; Patel JD; Benson AB; Perez EA; Gradishar WJ
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25217578
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry for predictive biomarkers in non-small cell lung cancer.
Mino-Kenudson M
Transl Lung Cancer Res; 2017 Oct; 6(5):570-587. PubMed ID: 29114473
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry of Lung Cancer Biomarkers.
Beasley MB
Adv Anat Pathol; 2024 Apr; ():. PubMed ID: 38666761
[TBL] [Abstract][Full Text] [Related]
9. Fit-for-Purpose Ki-67 Immunohistochemistry Assays for Breast Cancer.
Torlakovic EE; Baniak N; Barnes PJ; Chancey K; Chen L; Cheung C; Clairefond S; Cutz JC; Faragalla H; Gravel DH; Dakin Hache K; Iyengar P; Komel M; Kos Z; Lacroix-Triki M; Marolt MJ; Mrkonjic M; Mulligan AM; Nofech-Mozes S; Park PC; Plotkin A; Raphael S; Rees H; Seno HR; Thai DV; Troxell ML; Varma S; Wang G; Wang T; Wehrli B; Bigras G
Lab Invest; 2024 May; 104(7):102076. PubMed ID: 38729353
[TBL] [Abstract][Full Text] [Related]
10. Diffusion of molecular diagnostic lung cancer tests: a survey of german oncologists.
Steffen JA
J Pers Med; 2014 Mar; 4(1):102-14. PubMed ID: 25562146
[TBL] [Abstract][Full Text] [Related]
11. Endocrine Mucin-Producing Sweat Gland Carcinoma: Two New Eyelid Cases and Review of the Literature.
Nasser H; Siddiqui S
Int J Surg Pathol; 2020 Sep; 28(6):653-657. PubMed ID: 32188317
[TBL] [Abstract][Full Text] [Related]
12. Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis.
Son M; McEwan L; Ubaidat M; Bovell K; Morrow SA
Mult Scler; 2020 Nov; 26(13):1801-1803. PubMed ID: 32031458
[TBL] [Abstract][Full Text] [Related]
13. The Significance of a Knee Injury in the Investigation of an Unsuspected Motor Vehicle-Pedestrian Collision.
Halari MM; Shkrum MJ
Am J Forensic Med Pathol; 2020 Mar; 41(1):52-55. PubMed ID: 31895099
[TBL] [Abstract][Full Text] [Related]
14. Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP).
Cheung CC; Barnes P; Bigras G; Boerner S; Butany J; Calabrese F; Couture C; Deschenes J; El-Zimaity H; Fischer G; Fiset PO; Garratt J; Geldenhuys L; Gilks CB; Ilie M; Ionescu D; Lim HJ; Manning L; Mansoor A; Riddell R; Ross C; Roy-Chowdhuri S; Spatz A; Swanson PE; Tron VA; Tsao MS; Wang H; Xu Z; Torlakovic EE;
Appl Immunohistochem Mol Morphol; 2019; 27(10):699-714. PubMed ID: 31584451
[TBL] [Abstract][Full Text] [Related]
15. Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial.
García-Pardo M; Czarnecka-Kujawa K; Law JH; Salvarrey AM; Fernandes R; Fan ZJ; Waddell TK; Yasufuku K; Liu G; Donahoe LL; Pierre A; Le LW; Gunasegaran T; Ghumman N; Shepherd FA; Bradbury PA; Sacher AG; Schmid S; Corke L; Feng J; Stockley T; Pal P; Rogalla P; Pipinikas C; Howarth K; Ambasager B; Mezquita L; Tsao MS; Leighl NB
JAMA Netw Open; 2023 Jul; 6(7):e2325332. PubMed ID: 37490292
[TBL] [Abstract][Full Text] [Related]
16. Current State and Future Perspectives on Personalized Metabolomics.
Trifonova OP; Maslov DL; Balashova EE; Lokhov PG
Metabolites; 2023 Jan; 13(1):. PubMed ID: 36676992
[TBL] [Abstract][Full Text] [Related]
17. Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy.
Garcia-Pardo M; Czarnecka K; Law JH; Salvarrey A; Fernandes R; Fan J; Corke L; Waddell TK; Yasufuku K; Donahoe LL; Pierre A; Le LW; Ghumman N; Liu G; Shepherd FA; Bradbury P; Sacher A; Stockley T; Pal P; Rogalla P; Tsao MS; Leighl NB
Ther Adv Med Oncol; 2022; 14():17588359221126151. PubMed ID: 36158638
[TBL] [Abstract][Full Text] [Related]
18. Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer.
Kuang S; Fung AS; Perdrizet KA; Chen K; Li JJN; Le LW; Cabanero M; Karsaneh OAA; Tsao MS; Morganstein J; Ranich L; Smith AC; Wei C; Cheung C; Shepherd FA; Liu G; Bradbury P; Pal P; Schwock J; Sacher AG; Law JH; Stockley TL; Leighl NB
Curr Oncol; 2022 Jun; 29(7):4428-4437. PubMed ID: 35877212
[TBL] [Abstract][Full Text] [Related]
19. Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer-A Cost-Efficient Strategy in a Public Healthcare System.
Makarem M; Ezeife DA; Smith AC; Li JJN; Law JH; Tsao MS; Leighl NB
Curr Oncol; 2021 Aug; 28(5):3268-3279. PubMed ID: 34449580
[No Abstract] [Full Text] [Related]
20. Metabolomic Laboratory-Developed Tests: Current Status and Perspectives.
Lichtenberg S; Trifonova OP; Maslov DL; Balashova EE; Lokhov PG
Metabolites; 2021 Jun; 11(7):. PubMed ID: 34206934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
